Cite
HARVARD Citation
Ruperto, N. et al. (n.d.). THU0215 Long-Term Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis (SJIA): 5-Year Follow-up of An Open-Label Trial. Annals of the rheumatic diseases. pp. 265-266. [Online].